DAFTAR PUSTAKA

Alefan, Q., M. Izham, M. Ibrahim., Razak,T., Ayub, A. 2009. Cost of Treating

Hypertension In Malaysia.Asian Journal of Pharmaceutical and Clinical
Research. 2 (1).
Almasdy, D., Harisman., Kurniasih, N., Febriandi, H. 2014. Analisa Biaya Terapi
Penyakit Bronkopneumonia pada Suatu Rumah Sakit Pemerintah di Kota
Padang Sumatera Barat.Prosiding Seminar Nasional dan Workshop
“Perkembangan Terkini Sains Farmasi dan Klinik IV”.
Almasdy, D., Magfirah, A., Kurniasih, N. 2014. Cost Analysis on typoid Therapy in
Datu Beru Hospital Aceh Indonesia. Medan International Conference on
Advanced Pharmaceutical Sciences.
Anggriani, Y., Purwanggana, A., Subhan, A., Wardhani, Ria P. 2012. Evaluasi
Penggunaan dan Biaya Obat Antihipertensi pada Pasien Hipertensi Rawat Inap
di IRNA-B Rumah Sakit Umum Pusat Periode Juli-Desember 2010.Jurnal Ilmu
Kefarmasian Indonesia. 10 (2). ISSN: 1693-1831.
Athanasakis, K., Kyriakos, S., Yannis, T., John, Y., John, K., Angelos, H. 2014. A
Short-Term Cost-Effectiveness Analysis of Hypertension Treatment in
Greece.Hellenic J Cardiol 2014; 55: 197-203.
Bambungan, Y. M., Oetari, R.A., Satibi. 2017. Analisis Biaya Pengobatan Hipertensi
Pada Pasien Rawat Inap di RSUD Sorong.2-TRIK: Tunas-Tunas Riset
Kesehatan Jurnal Elektronik, Vol 7 (2): 72-76.
Bustan, M. N. 1997. Epidemiologi Penyakit Tidak Menular. Rineka Cipta. Jakarta
Chobanian, A.V., 2003. The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S
Department of Health and Human Services: National Heart, Lung and
Blood Institute.
Coylewright, M., Reckelhoff, J. F., & Ouyang, P. 2008. Menopause and
hypertension an age-old debate. Hypertension, 51(4), 952-959.
Crawford, Michael H. 2009. Current Diagnosis & Treatment Cardiology Third
Edition.USA: McGraw-Hill.
Da Costa, J.S.D., Fuchs, S.C., Olinto, M.T.A., Gigante, D.P. Menezes,
A.M.B.,Macedo, S., &Gehrke, S. 2002. Cost Effectiviness of Hipertension
treatment: a population-based study. Sao Paulo Medical Journal., 120 (4).
Dinas Kesehatan Kota Padang. 2015. Laporan Bulanan Data Kesehatan 2015. Padang
: Dinas Kesehatan Kota Padang.
Dipiro, J. T., Dipiro, C.V., Wells, B.G., & Scwinghammer, T.L. 2008.
Pharmacoteraphy Handbook Seventh Edition. USA : McGraw-Hill Company.
Frans, H.H., Leenen., Jean, D., Natalie, H., McInnis., et al. 2008. Results of the
Ontario Survey on the Prevalence and Control of Hypertension.Canadian
Medical Association Journal. 178 (11): 1441-1449.
Goodman & Gilman. 2012. Dasar Farmakologi Terapi Vol 2 Edisi 10. USA :
McGraw-Hill Company.
Jönsson, B., Hansson,L., Stålhammar, N.O. 2003. Health economics in the
Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of
intensive blood pressure lowering and low-dose aspirin in patients with
hypertension.J Intern Med.;253(4):472–80.
Juhwan, N., Hyeon, C. K., Anna, S., Hyungseon, Y., Suk, Y. J, et al. 2016.
Prevalence of Comorbidity among People with Hypertension: Korean
Circulation Journal. Vol 46 (5):672-680.
Kaplan, N. 2002. Hypertension in The Eldery SecondEdition.London: Martin Dunitz
Ltd.
Katzung, B.G. 2010. Farmakologi dasar dan Klinik. Jakarta : Penerbit Salemba
Medik.
Katzung, B.G. 2012. Basic & Clinical Pharmacology. Edisi 12. USA: McGraw-Hill.
Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K.,& He, J.
2005. Global Burden of Hypertension: Analysis of Worldwide Data. The
Lancet., 22(1), 11-19.
Kementrian Kesehatan Republik Indonesia. 2013. Buku Pegangan Sosialisasi
Jaminan Kesehatan Nasional (JKN) dalam Sistem Jaminan Sosial
Nasional,Jakarta : Kementrian Kesehatan Republik Indonesia.
Kementrian Kesehatan Republik Indonesia. 2013. Pedoman penerapan kajian
Farmakoekonomi.Jakarta : Kementrian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. 2013. Riset Kesehatan Dasar. Jakarta :
Badan Penelitian Dan Pengembangan Kesehatan Kementerian Kesehatan RI
Tahun 2013.
Kotchen, T A. 2012. Harrisons Principles of Internal Medicine, 19th Edition.USA:
McGraw-Hill.
Kumar, V., Cotran, R.S., Robbins, S.L. 2007. Buku Ajar Patologi. Edisi 7. Jakarta:
Penerbit Buku Kedokteran EGC.
Kurnia, R. 2009. Karekateristik Penderita Hipertensi Yang Dirawat Inap Di Bagian
Penyakit Dalam Rumah Sakit Umum Kota Padang Panjang Sumatera Barat
Tahun 2002-2006.(Skripsi). Medan: Universitas Sumatera Utara.
Lal, A.L.A., Ali, A., Amma, L.K.I., Vijayakumar, K. 2015. Cost Effectiveness of
Treating Hypertension in an Urban Area of Kerala State. India. Journal of
Health Systems. 2015 Oct 5;1(1):31–4
Lilly, L S. 2016. Pathophysiology of heart disease Edisi 6.Philadelphia, USA :
Wolters Kluwer.
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J. 2013. 2013 Practice guidelines for
the management ofarterial hypertension of the European Societyof
Hypertension (ESH) and the European Society ofCardiology (ESC). Journal of
Hypertension 2013, 31:1925–1938.
Moran, AE., Odden, MC., Thanataveerat,A., Tzong, KY. 2015. Cost-Effectiveness of
Hypertension Therapy According to 2014 Guidelines. N Engl J
Med2015;372:447-55
Nefrialdi. 2007. Obat kardiovaskular antihipertensi Dalam : Farmakologi dan
Terapi. Jakarta : Balai Penerbit FKUI.
Nilsson, P. M. 2008. Early Vascular Aging (EVA): Consequences And Prevention
.Vascular Health and Risk Management. Vol 4 (3):547-552.
Nguyen, T. P. L., Nguyen, T. B. Y., Nguyen, T. T., Hac, V. V., Le, H. H., et al. 2014.
Direct Costs of Hypertensive Patients Admitted to Hospital in Vietnam– a
bottom-up micro-costing Analysis. BMC Health Services Research.14:514.
Noor, A., Amrizal., Kang, WT., Rafidah., et al.Cost Analysis of Hypertension
Management in an Urban Primary Medical Centre Kuala Lumpur. Malaysian
Journal of Public Health Medicine 2014, Vol. 14 (3): 18-23.
Paczkowska, A., Koligat, D., Nowakowska, E., Hoffmann, K., Bryl, W. 2014.
Analysis of Direct Costs of Hypertension Treatment Among Adolescents in
Poland. Polish Pharmaceutical Society. Vol. 71 (1): 197-203.
Price, S A., Wilson, L M. 2006. Patofisiologi : Konsep Klinis Proses-Proses
Penyakit. Edisi 6 Vol 1. Jakarta : Kedokteran EGC.
Raffeza, Y.P. 2015. Analisis Biaya Terapi Hipertensi Oral Pasien Peserta Bpjs
Rawat Jalan di RSUP Dr. M. Djamil Padang. (Skripsi). Padang: Universitas
Andalas.
Rahajeng, B., Mazziyah, N., Hapsari, C.W., Krisnawati, L., 2014. Analisis Biaya
Pengobatan Hipertensi Sebagai PertimbanganDalam Penetapan Pembiayaan
Kesehatan Berdasar INA-CBGsPada Program Jaminan Kesehatan Nasional
2014 Di Rumah Sakit PKU Muhammadiyah Yogyakarta. (Laporan Penelitian).
Yogyakarta: Universitas Muhammadiyah Yogyakarta.
Rascati, K.L. 2009. Essentials of Pharmacoeconomics. Philadelphia :
Lippincott Williams & Wilkies.
Rascati, K.I., Drammond, M.F., Annemans, I., and Davey, P.G., 2004. Education In
Pharmacoeconomics: an International Multidiciplinary View (Review).
Pharmaco-Economics 2004; 22: 139-47.
Sanchez, L A. 2005. Pharmacoeconomic: principles, method and aplication, 1-9,
dalam Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., Hamilton, C.W.,
Pharmacoterapy Handbook Edisi 5. USA : Graw Hill Companies.
Saseen, J.J., & Maclaughlin, E.J. 2008. Hypertension. In Dipiro, J.T., Talbert, R.L.,
Yee, G.C., Matzke G.R., Wells, B.G., & Posey, L.M. (Ed.). Pharmacotherapy
A Pathophysiologic Approach Seventh Edition. USA: McGraw-Hill.
Susalit, E., Lubis. H.R. 2001. Ilmu Penyakit Dalam.Jakarta: FKUI.
Szucs, TD., Waeber, B., and Tomonag, Y. 2010. Cost-Effectiveness of
Antihypertensive Treatment in Patients 80 Years of Age Orolder in
Switzerland: an analysis Of TheHYVET study from a Swiss perspective.
Journal of Human Hypertension (2010) 24.
Vasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., et al.
2002.Residual Lifetime Risk for Developing Hypretension in Middle-Aged
Women and Men.JAMA.Vol 287 (8):1003-1010.
Vogenberg, F.R. 2001. Introduction To Applied Pharmacoeconomics. Editor: Zollo
S. USA : McGraw-Hill Companies.
Wells, B.G., Dipiro, J.T., Schwinghammer, T.L., & Dipiro, C.V.
2006.Pharmacotherapy Handbook Sixth Edition. USA: McGraw-Hill.
WHO. 2013. A global brief on hypertension, silent killer, global public health crisis.
Switzerland: WHO Press.
Wahyuningtiyas, D. A. 2015. Analisis Efektivitas Biaya Terapi Antihipertensi Pada
Pasien Hipertensi Rawat Inap di Rumah Sakit Umum Daerah Dr. Moewardi
tahun 2014. (Skripsi). Surakarta: Universitas Muhammadiyah Surakarta.
Wijayanti, N.W., Mukaddas, A., Tanda, M.R. 2016. Analisis Efektifitas Biaya
Pengobatan Kombinasi Amlodipin Furosemid Dibandingkan dengan
Kombinasi Amlodipin Bisoprolol pada Pasien Hipertensi Rawat Jalan di Rsud
Undata Palu Periode Agustus-Oktober T ahun 2014. Online Jurnal of Natural
Science Vol 5(1) : 101-11.
Yosida, I. 2016. Effektivitas Penggunaan Obat Antihipertensi di Instalasi Rawat Inap
Bangsal Bakung RSUD Panembahan Senopati Bantul Periode Agustus 2015.
(Skripsi). Yogyakarta: Universitas Sanata Dharma.